Mealey's (February 27, 2019, 9:27 AM EST) -- WASHINGTON, D.C. — In a Feb. 11 cross-appellant brief, Celltrion Healthcare Co. Ltd. defends a Massachusetts federal judge’s determination of noninfringement but disagrees with findings that Janssen Biotech Inc. is the sole owner of a disputed patent (Janssen Biotech Inc. v. Celltrion Healthcare Co. Ltd., Nos. 18-2321, 18-2350, Fed. Cir.)....